A Self-Adjuvanted, Modular, Antigenic VLP for Rapid Response to Influenza Virus Variability-Reference-Cited by-同舟云学术

A Self-Adjuvanted, Modular, Antigenic VLP for Rapid Response to Influenza Virus Variability

Published:2020-04-01 Issue:16 Volume:12 Page:18211-18224
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Sharma Jhanvi¹^ORCID,Shepardson Kelly²,Johns Laura L.²,Wellham Julia²,Avera John¹³,Schwarz Benjamin¹⁴,Rynda-Apple Agnieszka²,Douglas Trevor¹^ORCID

Affiliation:

1. Department of Chemistry, Indiana University, 800 E. Kirkwood Avenue, Bloomington, Indiana 47405, United States

2. Department of Microbiology and Immunology, Montana State University, Bozeman, Montana 59717, United States

3. Matrivax Research and Development Corporation, Boston, Massachusetts 02118, United Sates

4. Immunity to Pulmonary Pathogens section, Laboratory of Bacteriology, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana 59840, United States

Funder

National Institute of Allergy and Infectious Diseases

Division of Materials Research

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.9b21776

Reference109 articles.

1. Economic burden of seasonal influenza in the United States

2. WHO Influenza (Seasonal): https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal).

3. Influenza Pandemics of the 20th Century

4. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

5. Evolution of Influenza A Virus by Mutation and Re-Assortment

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plug and play virus-like particles for the generation of anti-toxin antibodies;Toxicon: X;2024-09

2. Single immunization with an influenza hemagglutinin nanoparticle‐based vaccine elicits durable protective immunity;Bioengineering & Translational Medicine;2024-06-03

3. Toward innovative veterinary nanoparticle vaccines;Animal Diseases;2024-05-10

4. Engineering protein nanoparticles for drug delivery;Current Opinion in Biotechnology;2024-04

5. Self‐Assembled Virus‐Like Particle Vaccines via Fluorophilic Interactions Enable Infection Mimicry and Immune Protection;Advanced Healthcare Materials;2023-09-22